Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey StudyJohannes Knitza, Axel J. Hueber, David Simón et al.|JMIR mhealth and uhealth|2020Cited by 215
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialJürgen Rech, Georg Schett, Martin Feuchtenberger et al.|The Lancet|2024Cited by 134
Accuracy, patient-perceived usability, and acceptance of two symptom checkers (Ada and Rheport) in rheumatology: interim results from a randomized controlled crossover trialJohannes Knitza, Martin Welcker, Jacob Mohn et al.|Arthritis Research & Therapy|2021Cited by 73
Quality of a Supporting Mobile App for Rheumatic Patients: Patient-Based Assessment Using the User Version of the Mobile Application Scale (uMARS)Antonia Lambrecht, Johannes Knitza, Nicolas Vuillerme et al.|Frontiers in Medicine|2021Cited by 63
Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugsDavid Simón, Asmir Vodenčarević, Koray Taşçılar et al.|Arthritis Research & Therapy|2021Cited by 60